[Federal Register Volume 87, Number 229 (Wednesday, November 30, 2022)]
[Notices]
[Pages 73539-73540]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-26101]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-32-2022]


Foreign-Trade Zone (FTZ) 27--Boston, Massachusetts; Authorization 
of Production Activity; Wyeth Pharmaceuticals, LLC (COVID-19 Vaccine), 
Andover, Massachusetts

    On July 27, 2022, Wyeth Pharmaceuticals, LLC, submitted a 
notification of proposed production activity to the FTZ Board for its 
facility within Subzone 27R, in Andover, Massachusetts.
    The notification was processed in accordance with the regulations 
of the FTZ Board (15 CFR part 400), including notice in the Federal 
Register inviting public comment (87 FR 47962, August 5, 2022). On 
November 25, 2022, the

[[Page 73540]]

applicant was notified of the FTZ Board's decision that no further 
review of the activity is warranted at this time. The production 
activity described in the notification was authorized, subject to the 
FTZ Act and the FTZ Board's regulations, including Section 400.14.

    Dated: November 25, 2022.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2022-26101 Filed 11-29-22; 8:45 am]
BILLING CODE 3510-DS-P